Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $192.2700 (0.15%) ($192.2700 - $192.8000) on Mon. Jul. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.98% (three month average) | RSI | 27 | Latest Price | $192.2700(0.15%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) FXI(28%) KWEB(28%) EEM(26%) EWY(26%) MCHI(26%) | Factors Impacting SGEN price | SGEN will decline at least -0.49% in a week (0% probabilities). UUP(-13%) VXX(-12%) XOP(-10%) VIXM(-10%) UNG(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.49% (StdDev 0.98%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $195.38 | 5 Day Moving Average | $192.83(-0.29%) | 10 Day Moving Average | $193.4(-0.58%) | 20 Day Moving Average | $195.38(-1.59%) | To recent high | -6.9% | To recent low | 2.2% | Market Cap | $33.429b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |